Precigen
PGEN
Precigen (PGEN) news
Recent news
Precigen, Inc.: H.C. Wainwright raises target price to $18 from $14
AInvest Wire · Aug 5, 2026Precigen Q2 revenue USD 54.978 million
AInvest Wire · Aug 4, 2026Precigen Q2 EPS USD 0.05
AInvest Wire · Aug 4, 2026Precigen 2Q revenue $55.0M, estimate $27.8M
AInvest Wire · Aug 4, 2026Precigen, - Papzimeos revenue drives company to quarterly profitability
Precigen, Inc. (Nasdaq: PGEN) reported strong financial performance for the first quarter of 2026, driven by the continued commercial success of its flagship product, PAPZIMEOS™. The company generated $21.6 million in net product revenue during the quarter, reflecting broad-based adoption of the…
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.